Cuevas, Fahiza .

HRN: 28-68-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/25/2026
04/01/2026
IV
1.7g
Q8
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: